Emily Wiecek, O.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vision Disorders | 5 | 2021 | 1018 | 1.350 |
Why?
|
| Vision, Binocular | 3 | 2021 | 205 | 1.290 |
Why?
|
| Convergence, Ocular | 1 | 2021 | 24 | 0.810 |
Why?
|
| Refractive Errors | 1 | 2022 | 137 | 0.770 |
Why?
|
| Myopia | 1 | 2022 | 250 | 0.710 |
Why?
|
| Pattern Recognition, Visual | 2 | 2014 | 831 | 0.620 |
Why?
|
| Vision Tests | 2 | 2014 | 157 | 0.610 |
Why?
|
| Retinopathy of Prematurity | 1 | 2022 | 418 | 0.600 |
Why?
|
| Macular Degeneration | 2 | 2014 | 962 | 0.560 |
Why?
|
| Visual Acuity | 5 | 2021 | 2457 | 0.530 |
Why?
|
| Vision, Monocular | 1 | 2014 | 73 | 0.490 |
Why?
|
| Scotoma | 1 | 2012 | 140 | 0.400 |
Why?
|
| Eye Movements | 2 | 2021 | 497 | 0.390 |
Why?
|
| Retinal Diseases | 1 | 2014 | 666 | 0.330 |
Why?
|
| Visual Fields | 1 | 2014 | 1039 | 0.310 |
Why?
|
| Epiretinal Membrane | 2 | 2014 | 68 | 0.250 |
Why?
|
| Geographic Atrophy | 2 | 2014 | 61 | 0.250 |
Why?
|
| Wet Macular Degeneration | 2 | 2014 | 141 | 0.220 |
Why?
|
| Contrast Sensitivity | 2 | 2014 | 234 | 0.220 |
Why?
|
| Mydriatics | 1 | 2022 | 68 | 0.210 |
Why?
|
| Accommodation, Ocular | 1 | 2021 | 50 | 0.200 |
Why?
|
| Fovea Centralis | 1 | 2021 | 116 | 0.190 |
Why?
|
| Intravitreal Injections | 1 | 2022 | 339 | 0.190 |
Why?
|
| Laser Coagulation | 1 | 2022 | 323 | 0.180 |
Why?
|
| Models, Statistical | 1 | 2014 | 5081 | 0.180 |
Why?
|
| Visual Field Tests | 1 | 2021 | 371 | 0.170 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 212 | 0.170 |
Why?
|
| Tomography, Optical Coherence | 2 | 2021 | 2517 | 0.140 |
Why?
|
| Microscopy, Acoustic | 1 | 2014 | 42 | 0.130 |
Why?
|
| Spatial Behavior | 1 | 2014 | 91 | 0.130 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2014 | 25 | 0.130 |
Why?
|
| Amblyopia | 1 | 2015 | 138 | 0.120 |
Why?
|
| Gestational Age | 1 | 2022 | 3443 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2014 | 23178 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2022 | 2030 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2021 | 1108 | 0.100 |
Why?
|
| Macular Edema | 1 | 2014 | 345 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2021 | 1262 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2022 | 74145 | 0.070 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 1187 | 0.070 |
Why?
|
| Humans | 10 | 2022 | 725001 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2022 | 24980 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8555 | 0.050 |
Why?
|
| Middle Aged | 5 | 2015 | 212155 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 24043 | 0.050 |
Why?
|
| Infant | 1 | 2022 | 34331 | 0.050 |
Why?
|
| Male | 6 | 2021 | 346964 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2022 | 39883 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57615 | 0.040 |
Why?
|
| Female | 5 | 2021 | 375303 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 84411 | 0.040 |
Why?
|
| Aged | 3 | 2014 | 161379 | 0.040 |
Why?
|
| Incidence | 1 | 2014 | 20743 | 0.040 |
Why?
|
| Prognosis | 1 | 2014 | 28718 | 0.030 |
Why?
|
| Child | 1 | 2021 | 75163 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 55791 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2036 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 6878 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 70971 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 211523 | 0.010 |
Why?
|